These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21077849)

  • 21. Inhibition of glucose- and calcium-induced insulin secretion from betaTC3 cells by novel inhibitors of protein isoprenylation.
    Amin R; Chen HQ; Tannous M; Gibbs R; Kowluru A
    J Pharmacol Exp Ther; 2002 Oct; 303(1):82-8. PubMed ID: 12235236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome.
    Efuet ET; Keyomarsi K
    Cancer Res; 2006 Jan; 66(2):1040-51. PubMed ID: 16424040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells.
    Duque G; Rivas D
    J Bone Miner Res; 2007 Oct; 22(10):1603-11. PubMed ID: 17605634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.
    Ohe JY; Kwon YD; Lee HW
    Clin Oral Investig; 2012 Aug; 16(4):1153-9. PubMed ID: 21938481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.
    Di Paolo A; Danesi R; Caputo S; Macchia M; Lastella M; Boggi U; Mosca F; Marchetti A; Del Tacca M
    Br J Cancer; 2001 Jun; 84(11):1535-43. PubMed ID: 11384105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
    Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
    Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5'-hydroxy Auraptene stimulates osteoblast differentiation of bone marrow-derived mesenchymal stem cells via a BMP-dependent mechanism.
    Abdallah BM; Ali EM
    J Biomed Sci; 2019 Jul; 26(1):51. PubMed ID: 31277646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis.
    Duque G; Huang DC; Macoritto M; Rivas D; Yang XF; Ste-Marie LG; Kremer R
    Stem Cells; 2009 Mar; 27(3):550-8. PubMed ID: 19096039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immobilization of alendronate on titanium via its different functional groups and the subsequent effects on cell functions.
    Zheng D; Neoh KG; Kang ET
    J Colloid Interface Sci; 2017 Feb; 487():1-11. PubMed ID: 27743540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Ras and related G-proteins as a therapeutic strategy for blocking malignant glioma growth.
    Bredel M; Pollack IF; Freund JM; Hamilton AD; Sebti SM
    Neurosurgery; 1998 Jul; 43(1):124-31; discussion 131-2. PubMed ID: 9657198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis.
    Maria S; Samsonraj RM; Munmun F; Glas J; Silvestros M; Kotlarczyk MP; Rylands R; Dudakovic A; van Wijnen AJ; Enderby LT; Lassila H; Dodda B; Davis VL; Balk J; Burow M; Bunnell BA; Witt-Enderby PA
    J Pineal Res; 2018 Apr; 64(3):. PubMed ID: 29285799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using the Connectivity Map to discover compounds influencing human osteoblast differentiation.
    Brum AM; van de Peppel J; Nguyen L; Aliev A; Schreuders-Koedam M; Gajadien T; van der Leije CS; van Kerkwijk A; Eijken M; van Leeuwen JPTM; van der Eerden BCJ
    J Cell Physiol; 2018 Jun; 233(6):4895-4906. PubMed ID: 29194609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts.
    Dey D; Jingar P; Agrawal S; Shrivastava V; Bhattacharya A; Manhas J; Garg B; Ansari MT; Mridha AR; Sreenivas V; Khurana A; Sen S
    J Ethnopharmacol; 2020 Feb; 248():112329. PubMed ID: 31672526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of GGTase-I and FTase disrupts cytoskeletal organization of human PC-3 prostate cancer cells.
    Virtanen SS; Sandholm J; Yegutkin G; Kalervo Väänänen H; Härkönen PL
    Cell Biol Int; 2010 Aug; 34(8):815-26. PubMed ID: 20446922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
    Ebert R; Zeck S; Krug R; Meissner-Weigl J; Schneider D; Seefried L; Eulert J; Jakob F
    Bone; 2009 May; 44(5):858-64. PubMed ID: 19442618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro.
    Masterson R; Kelynack K; Hewitson T; Becker G
    Nephron Exp Nephrol; 2006; 102(1):e19-29. PubMed ID: 16179803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells.
    Mazet JL; Padieu M; Osman H; Maume G; Mailliet P; Dereu N; Hamilton AD; Lavelle F; Sebti SM; Maume BF
    FEBS Lett; 1999 Oct; 460(2):235-40. PubMed ID: 10544242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation.
    McGuire TF; Qian Y; Vogt A; Hamilton AD; Sebti SM
    J Biol Chem; 1996 Nov; 271(44):27402-7. PubMed ID: 8910319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche.
    Birmingham E; Niebur GL; McHugh PE; Shaw G; Barry FP; McNamara LM
    Eur Cell Mater; 2012 Jan; 23():13-27. PubMed ID: 22241610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs affecting prelamin A processing: effects on heterochromatin organization.
    Mattioli E; Columbaro M; Capanni C; Santi S; Maraldi NM; D'Apice MR; Novelli G; Riccio M; Squarzoni S; Foisner R; Lattanzi G
    Exp Cell Res; 2008 Feb; 314(3):453-62. PubMed ID: 18093584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.